Distributed Bio Inc Information

MISSION Our mission is to define a new paradigm in revolutionary bioengineered medicines for the entire biotechnology industry. In monoclonal therapeutics, our integration of computational immunology, bioengineering and robotics has enabled us to create a pipeline of molecules with unprecedented biophysical properties, while also supporting all of our partners with thousands of high affinity developable antibodies against any drug target of interest. In vaccine science, our viral protein engineering is producing universal vaccines against any rapidly mutating virus. OUR TECHNOLOGIES The AbGenesis repertoire analysis and engineering environment enables the analysis of individual cells to millions of B-cell and T-cell receptors, as well as linking of sequence and phenotype data. Our SuperHuman2.0 antibody discovery technology has the unique ability to generate thousands of best-in-class molecules against 26 critical immune oncology and neurodegeneration targets, enabling our partners to save years of research time. The Tumbler Technology makes hundreds of millions of variants of a starting antibody, allowing us to select across a vast local search space for biosuperiors with remarkable new characteristics. Finally, our patented breakthrough epitope focusing technology, Centivax, enables vaccines against rapidly mutating pathogens such as influenza, HIV, and the flaviviruses, allowing Universal Vaccine design. If you are looking to discover or engineer antibodies, contact us.